On Thursday, analystPablo ZuanicfromCantor Fitzgeraldoffered an industry update on four recent M&A deals andGlasshouse Series B Preferred stock issuance.
Highlights
- Zuanic said the deal betweenCuraleaf Holdings Inc.(NASDAQ:CRBLF) andFour20 Pharmastands out from the rest, because it could have the greatest long term strategic implications "especially if Curaleaf international goes for a NASDAQ listing (in the event US MSOs do not have a line of sight on listing themselves)."
- RegardingSNDL (NASDAQ:SNDL) buying Valens (TSE: VLNS), Zuanic said the deal helps the company develop its Canadian recreational moat, more than doubling...
ログインすると全部閲覧できます。
ログイン